New Seattle precision medicine institute will catalog 60K breast cancer gene mutations

A $50 million donation by Jeffrey and Susan Brotman and Pam and Dan Baty will help create the Brotman Baty Institute for Precision Medicine, according to a recent University of Washington news release. The institute will combine the expertise of UW Medicine, Fred Hutchinson Cancer Research Center in Seattle and Seattle Children's Hospital.  

According to the release, one of the institute's first projects will be to catalog an estimated 60,000 possible mutations of the BRCA1 and BRCA2 genes in young women to help them make more informed health decisions in hopes of preventing and treating breast cancer.  

The Brotman Baty Institute for Precision Medicine, a gift in honor of the legacy of the late Costco co-founder and Dan Baty's friend and business partner Jeff Brotman, will have researchers using a precision medicine approach relying on research and patient care that uses information from genetic molecular profiling to optimize patient diagnosis, treatment and therapy.

"What attracted Jeff to precision medicine is that it will be a total transformation of how doctors can treat and heal," said Baty, founder of the private equity firm Columbia Pacific Management. "And what attracted all of us is that the three partner organizations have the expertise and the collaborative culture to make precision medicine a success." 

See the original press release here for more information about the Brotman Baty Institute for Precision Medicine.